Kenneth J. Bender, PharmD, MA

September 08, 2017

Terms such as "opioid McCarthyism" and "witch hunt" were used to express frustration with current opioid regulatory efforts.

September 07, 2017

From PAINWeek 2017: Reflex vasodilation is out, neurobiologic dysfunction is in as explanation for migraine etiology.

September 06, 2017

An early session at PAINWeek 2017 addressed prescriber fear as regulatory agencies "pile on" across overlapping jurisdictions.

June 16, 2017

Studies summarized in this slide show focus on fine-tuning insulin-containing regimens to enhance glucose control and avoid variability.

June 15, 2017

Glycemic variability fuels hypoglycemia but in one study from ADA 2017 is found to actually help predict hypoglycemic events.

June 14, 2017

Cardiovascular risk/benefit profiles of pioglitazone and the SGLT2 inhibitor class are summarized, based on reports at ADA 2017.

June 13, 2017

A1C vs FPG to diagnose prediabetes; prediabetes and CHF; and how much weight loss is too much? Reports from ADA 2017.

June 12, 2017

Insulin degludec vs glargine--which costs less per anum and why? We summarize this study and 2 other direct insulin comparisons reported at ADA 2017.

June 12, 2017

When to start screening for B12 deficiency in your diabetes patients taking metformin? We review a dose-response diet study plus 2 others on oral drugs.

September 14, 2016

"Ladies and gentlemen of the jury," began the PAINWeek 2016 speaker, in mock trial defense of a physician for over-prescribing opioid meds.